Cyrus V. Hedvat

13.2k total citations · 1 hit paper
76 papers, 5.4k citations indexed

About

Cyrus V. Hedvat is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Cyrus V. Hedvat has authored 76 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 24 papers in Hematology and 22 papers in Molecular Biology. Recurrent topics in Cyrus V. Hedvat's work include Acute Myeloid Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Immunotherapy and Immune Responses (9 papers). Cyrus V. Hedvat is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Immunotherapy and Immune Responses (9 papers). Cyrus V. Hedvat collaborates with scholars based in United States, France and Netherlands. Cyrus V. Hedvat's co-authors include Ross L. Levine, Omar Abdel‐Wahab, Jay Patel, Julie Teruya‐Feldstein, Valeria R. Fantin, Kim A. Sharp, Justin R. Cross, Joshua D. Rabinowitz, Alexander E. Perl and Martin Carroll and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Cyrus V. Hedvat

75 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

2010 1.5k citations Patrick S. Ward, Jay Patel et al. Cancer Cell profile →

Peers

Countries citing papers authored by Cyrus V. Hedvat

Since Specialization

Citations

This map shows the geographic impact of Cyrus V. Hedvat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrus V. Hedvat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrus V. Hedvat more than expected).

Fields of papers citing papers by Cyrus V. Hedvat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyrus V. Hedvat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrus V. Hedvat. The network helps show where Cyrus V. Hedvat may publish in the future.

Co-authorship network of co-authors of Cyrus V. Hedvat

This figure shows the co-authorship network connecting the top 25 collaborators of Cyrus V. Hedvat. A scholar is included among the top collaborators of Cyrus V. Hedvat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyrus V. Hedvat. Cyrus V. Hedvat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Classification of the Tumor Immune Microenvironment Using Machine-Learning-Based CD8 Immunophenotyping As a Potential Biomarker for Immunotherapy and TGF-β Blockade in Nonsmall Cell Lung Cancer 2024 ·Robert J. Pomponio, Hong Wang, (unknown), (unknown), Roger Trullo, Joon Sang Lee, Brigitte Demers, (unknown), (unknown), (unknown), Cyrus V. Hedvat, (unknown), Rui Wang	3
2	Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors 2023 ·ESMO Open ·(unknown), Vipul Baxi, (unknown), (unknown), Cyrus V. Hedvat, (unknown), Alice M. Walsh, Xiaofeng Shao, (unknown), Danielle Greenawalt, Poliana Patah, Ruslan D. Novosiadly	5
3	Development of a LAG-3 immunohistochemistry assay for melanoma 2022 ·Journal of Clinical Pathology ·(unknown), Bryan K. McCune, Darren Locke, Cyrus V. Hedvat, John Wojcik, (unknown), Jim Yan, (unknown), Angela Sanders-Cliette, (unknown), Lloye M. Dillon, Steven M. Anderson, Jeffrey R. Shuster	8
4	New Technologies to Image Tumors 2020 ·Cancer treatment and research ·George McNamara, Justin Lucas, John F. Beeler, Ajay Basavanhally, George Lee, Cyrus V. Hedvat, Vipul Baxi, Darren Locke, Alexander D. Borowsky, Richard M. Levenson	4
5	Detection of Mutations in Myeloid Malignancies through Paired-Sample Analysis of Microdroplet-PCR Deep Sequencing Data 2014 ·Journal of Molecular Diagnostics ·Donavan T. Cheng, Janice Cheng, Talia Mitchell, Aijazuddin Syed, Ahmet Zehir, Nana Yaa Mensah, (unknown), Khédoudja Nafa, Ross L. Levine, Maria E. Arcila, Michael F. Berger, Cyrus V. Hedvat	17
6	Disruption of Abi1/Hssh3bp1 expression induces prostatic intraepithelial neoplasia in the conditional Abi1/Hssh3bp1 KO mice 2012 ·Oncogenesis ·Xiufang Xiong, Anna Chorzalska, Patrycja M. Dubielecka, Julie R. White, Yogindra Vedvyas, Cyrus V. Hedvat, Adriana Haimovitz‐Friedman, Jason A. Koutcher, Jüri Reimand, Gary D. Bader, Janet A. Sawicki, Leszek Kotula	16
7	Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases 2012 ·Annals of Surgical Oncology ·Steven C. Katz, Zubin M. Bamboat, Ajay V. Maker, Jinru Shia, Venu G. Pillarisetty, Adam C. Yopp, Cyrus V. Hedvat, Mithat Gönen, William R. Jarnagin, Yuman Fong, Michael I. D’Angelica, Ronald P. DeMatteo	132
8	Late relapse in primary central nervous system lymphoma: clonal persistence 2011 ·Neuro-Oncology ·Lakshmi Nayak, Cyrus V. Hedvat, Marc K. Rosenblum, Lauren E. Abrey, Lisa M. DeAngelis	49
9	Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias 2010 ·Cancer Research ·Omar Abdel‐Wahab, Taghi Manshouri, Jay Patel, Kelly L. Harris, JinJuan Yao, Cyrus V. Hedvat, Adriana Heguy, Carlos Bueso-Ramos, Hagop M. Kantarjian, Ross L. Levine, Srđan Verstovšek	227
10	The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate breakdown → 2010 ·Cancer Cell ·Patrick S. Ward, Jay Patel, David R. Wise, Omar Abdel‐Wahab, Bryson D. Bennett, Hilary A. Coller, Justin R. Cross, Valeria R. Fantin, Cyrus V. Hedvat, Alexander E. Perl, Joshua D. Rabinowitz, Martin Carroll, Shinsan M. Su, Kim A. Sharp, Ross L. Levine, Craig B. Thompson	1483
11	PIK3CA Mutation Associates with Improved Outcome in Breast Cancer 2009 ·Clinical Cancer Research ·Kevin Kalinsky, Lindsay M. Jacks, Adriana Heguy, Sujata Patil, Marija Drobnjak, Umesh Bhanot, Cyrus V. Hedvat, Tiffany A. Traina, David B. Solit, William L. Gerald, Mary Ellen Moynahan	299
12	T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases 2009 ·Annals of Surgical Oncology ·Steven C. Katz, Venu G. Pillarisetty, Zubin M. Bamboat, Jinru Shia, Cyrus V. Hedvat, Mithat Gönen, William R. Jarnagin, Yuman Fong, Leslie H. Blumgart, Michael I. D’Angelica, Ronald P. DeMatteo	110
13	Expression of epithelial membrane protein‐2 is associated with endometrial adenocarcinoma of unfavorable outcome 2006 ·Cancer ·Madhuri Wadehra, Sathima Natarajan, David B. Seligson, Carmen J. Williams, Amanda Hummer, Cyrus V. Hedvat, Jonathan Braun, Robert A. Soslow	45
14	Lysophosphatidic acid acyltransferase‐β (LPAAT‐β) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival 2006 ·Cancer ·Catherine Diefenbach, Robert A. Soslow, Alexia Iasonos, Irina Linkov, Cyrus V. Hedvat, Lynn Bonham, Jack W. Singer, Richard R. Barakat, Carol Aghajanian, Jakob Dupont	38
15	Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial 2005 ·Bone Marrow Transplantation ·Sunil Gupta, Ping Zhou, Hani Hassoun, Tarun Kewalramani, Lilian Reich, (unknown), Lisa A. Drake, Virginia M. Klimek, Madhav V. Dhodapkar, Julie Teruya‐Feldstein, Cyrus V. Hedvat, Nagesh Kalakonda, Martin Fleisher, D Filippa, Jing Qin, Stephen D. Nimer, Raymond L. Comenzo	15
16	Expression of p63 in Diffuse Large B-Cell Lymphoma 2005 ·Applied immunohistochemistry & molecular morphology ·Cyrus V. Hedvat, Julie Teruya‐Feldstein, Pere Puig, Paola Capodieci, Mária Dudás, Natalie Pica, Jing Qin, Carlos Cordon‐Cardo, Charles J. Di Como	40
17	Expression of cancer–testis antigens in endometrial carcinomas using a tissue microarray 2004 ·Modern Pathology ·Dhananjay Chitale, Achim A. Jungbluth, (unknown), Mario M. Leitão, Cyrus V. Hedvat, Denise Kolb, Giulio C. Spagnoli, Kristin Iversen, Robert A. Soslow	29
18	Melan-A (A103) and Inhibin Expression in Ovarian Neoplasms 2003 ·Applied immunohistochemistry & molecular morphology ·Davis X. Yao, Robert A. Soslow, Cyrus V. Hedvat, Mario M. Leitão, Rebecca N. Baergen	27
19	p63 expression profiles in human normal and tumor tissues. 2002 ·PubMed ·Charles J. Di Como, Marshall Urist, Irina Babayan, Marija Drobnjak, Cyrus V. Hedvat, Julie Teruya‐Feldstein, (unknown), Axel Hoos, Carlos Cordon‐Cardo	432
20	The ETS Protein MEF Plays a Critical Role in Perforin Gene Expression and the Development of Natural Killer and NK-T Cells 2002 ·Immunity ·H. Daniel Lacorazza, Yasushi Miyazaki, Antonio Di Cristofano, A DeBlasio, Cyrus V. Hedvat, Jin Zhang, Carlos Cordon‐Cardo, Shifeng Mao, Pier Paolo Pandolfi, Stephen D. Nimer	162

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact